The evidence base of proton pump inhibitor chemopreventative agents in Barrett's esophagus--the good, the bad, and the flawed!
Gastric acid is believed to be an important etiological factor in the pathogenesis of Barrett's esophagus. Pulsatile acid exposure increases cell proliferation in ex vivo Barrrett's tissue and normalization of esophageal pH reverses this. Proton pump inhibitors (PPIs) are the mainstay of t...
المؤلفون الرئيسيون: | Leedham, S, Jankowski, J |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2007
|
مواد مشابهة
-
Proton Pump Inhibitors (PPIs): The culprit for Barrett’s esophagus?
حسب: Omran eAlsalahi, وآخرون
منشور في: (2015-01-01) -
Barrett’s Esophagus: Is It All That Bad?
حسب: GNJ Tytgat
منشور في: (1999-01-01) -
Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
حسب: Harry Snady
منشور في: (2023-12-01) -
Mapping clonality in individual glands in human Barrett's esophagus
حسب: Leedham, S, وآخرون
منشور في: (2007) -
Gingers and Their Purified Components as Cancer Chemopreventative Agents
حسب: John F. Lechner, وآخرون
منشور في: (2019-08-01)